Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic
D. Dalla Gasperina
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorM.L. Balsamo
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorS.D. Garavaglia
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorF. Rovida
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for more papers by this authorF. Baldanti
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for more papers by this authorCorresponding Author
P.A. Grossi
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Correspondence to:
Prof. Paolo Antonio Grossi, Professor of Infectious Diseases, Department of Surgical and Morphological Sciences, Section of Infectious Diseases, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Viale Borri, 57, Varese 21100, Italy
Tel: +390332393075
Fax: +390332393080
E-mail: [email protected]
Search for more papers by this authorD. Dalla Gasperina
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorM.L. Balsamo
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorS.D. Garavaglia
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Search for more papers by this authorF. Rovida
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for more papers by this authorF. Baldanti
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Search for more papers by this authorCorresponding Author
P.A. Grossi
Department of Surgical and Morphological Sciences of Clinical Medicine, Section of Infectious Diseases, University of Insubria, Varese, Italy
Correspondence to:
Prof. Paolo Antonio Grossi, Professor of Infectious Diseases, Department of Surgical and Morphological Sciences, Section of Infectious Diseases, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Viale Borri, 57, Varese 21100, Italy
Tel: +390332393075
Fax: +390332393080
E-mail: [email protected]
Search for more papers by this authorAbstract
Since December 2013, chikungunya virus (CHIKV) spread in many countries of the Western Hemisphere, and during the last year some cases of infected European travelers, coming back from the Caribbean, have been reported. The risk of acquiring severe travel-related illness is higher in immunocompromised subjects, such as patients with human immunodeficiency virus (HIV) infection or solid organ transplant recipients. We reported the first case, to our knowledge, of CHIKV infection in an HIV-infected kidney transplant recipient.
References
- 1Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M. Emergence of chikungunya fever on the French side of Saint Martin Island, October to December 2013. Euro Surveill 2014; 19 (13): pii=20752.
10.2807/1560-7917.ES2014.19.13.20752 Google Scholar
- 2Cauchemez S, Ledrans M, Poletto C, et al. Local and regional spread of chikungunya fever in the Americas. Euro Surveill 2014; 19 (28): pii=20854.
10.2807/1560-7917.ES2014.19.28.20854 Google Scholar
- 3 Pan American Health Organization (PAHO). Number of Reported Cases of Chikungunya Fever in the Americas, by Country or Territory with Autochthonous Transmission 2013–2015 (to Week Noted). Epidemiological week/EW 8 (Updated as of 27 February 2015). Washington, DC: World Health Organization Regional Office for the Americas, 2015. Available from: http://www.paho.org/hq/index.php?option=com_topics&view=article&id=343&Itemid=40931
- 4 European Centre for Disease Prevention and Control (ECDC). Rapid Risk Assessment. Chikungunya Outbreak in Caribbean Region, 25 June 2014. Stockholm: ECDC, 2014. Available from: http://ecdc.europa.eu/en/publications/Publications/chikungunya-caribbean-June-2014-risk-assessment.pdf
- 5Requena-Méndez A, García C, Aldasoro E, et al. Cases of chikungunya virus infection in travellers returning to Spain from Haiti or Dominican Republic, April–June 2014. Euro Surveill 2014; 19 (28): pii=20853.
10.2807/1560-7917.ES2014.19.28.20853 Google Scholar
- 6Paty MC, Six C, Charlet F, et al. Large number of imported chikungunya cases in mainland France, 2014: a challenge for surveillance and response. Euro Surveill 2014; 19 (28): pii=20856.
10.2807/1560-7917.ES2014.19.28.20856 Google Scholar
- 7 Institut de Veille Sanitaire. Chikungunya et dengue – Données de la surveillance renforcée en France métropolitaine en 2014: Institut de Veille Sanitaire, 2014 [updated as of 30 November 2014]. Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-transmission-vectorielle/Chikungunya/Donnees-epidemiologiques/France-metropolitaine/Chikungunya-et-dengue-Donnees-de-la-surveillance-renforcee-en-France-metropolitaine-en-2014
- 8 Centro Nazionale di Epidemiologia – Sorveglianza e Promozione della Salute. Febbre Chikungunya: aumento del numero dei casi importati in Italia nel primo semestre del 2014 [cited 25 June 2014]. Available from: http://www.epicentro.iss.it/problemi/Chikungunya/AumentoCasi2014.asp
- 9Noël H, Rizzo C. Spread of chikungunya from the Caribbean to mainland Central and South America: a greater risk of spillover in Europe? Euro Surveill 2014; 19 (28): pii=20855.
10.2807/1560-7917.ES2014.19.28.20855 Google Scholar
- 10Farnon EC, Sejvar JJ, Staples JE. Severe disease manifestations associated with acute chikungunya virus infection. Crit Care Med 2008; 36 (9): 2682–2683.
- 11Economopoulou A, Dominguez M, Helynck BA, et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion. Epidemiol Infect 2009; 137: 534–541.
- 12Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet 2012; 379 (9816): 662–671.
- 13Kee ACL, Yang S, Tambyah P. Atypical chikungunya virus infections in immunocompromised patients. Emerg Infect Dis 2010; 16 (6): 1038–1040.
- 14Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 2015; 372 (13): 1231–1239.
- 15Ahola T, Courderc T, Ng LFP, et al. Therapeutics and vaccines against chikungunya virus. Vector Borne Zoonotic Dis 2015; 15 (4): 250–257.
- 16Ravichandran R, Manian M. Ribavirin therapy for chikungunya arthritis. J Infect Dev Ctries 2008; 2: 140–142.
- 17Briolant S, Garin D, Scaramizzino N, Jouan A, Crance JM. In vitro inhibition of chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 2004; 61: 111–117.
- 18Delang L, Segura Guerrero N, Tas A, et al. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J Antimicrob Chemother 2014; 69: 2770–2784.
- 19Pastorino B, Bessaud M, Grandadam M, Murri S, Tolou HJ, Peyrefitte CN. Development of a TaqMan® RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. J Virol Meth 2005; 124: 65–71.
- 20Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 2013; 99: 345–370.
- 21Staples JE, Fischer M. Chikungunya virus in the Americas – what a vectorborne pathogen can do. N Engl J Med 2014; 371 (10): 887–889.
- 22 World Health Organization (WHO). Guidelines for prevention and control of chikungunya fever. Available from: http://www.searo.who.int/LinkFiles/Publication_SEA-CD-182.pdf (accessed August 1, 2011).
- 23Pialoux G, Gaüzère B-A, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7 (5): 319–327.
- 24Komar O, Robbins MB, Klenk K, et al. West Nile virus transmission in resident birds, Dominican Republic. Emerg Infect Dis 2003; 9: 1299–1302.
- 25Komar O, Robbins MB, Contreras GG, et al. West Nile virus survey of birds and mosquitoes in the Dominican Republic. Vector Borne Zoonotic Dis 2005; 5: 120–126.
- 26Elizondo-Quiroga D, Elizondo-Quiroga A. West Nile virus and its theories, a big puzzle in Mexico and Latin America. J Glob Infect Dis 2013; 5 (4): 168–175.
- 27 Centers for Disease Control Health Information for International Travel. The Yellow Book. Centers for Disease Control: Atlanta, GA, 2012.
- 28Kotton CN, Hibberd PL; the AST Infectious Diseases Community of Practice. Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant 2013; 13: 337–347.
- 29Grossi PA, Fishman JA, the AST Infectious Disease Community of Practice. Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S19–S26.
